ScholarIQanswers from OpenAlex & ORCID
Gerhard Ehninger
ResearcherPublications, citations & collaboration network
Gerhard Ehninger is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Gerhard Ehninger have?
ScholarIQindexed works
Gerhard Ehninger has 1,215 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Gerhard Ehninger have?
ScholarIQcitation count
Gerhard Ehninger has 49,811 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Gerhard Ehninger?
ScholarIQh-index
Gerhard Ehninger has an h-index of 105 in OpenAlex.
What is the i10-index of Gerhard Ehninger?
ScholarIQi10-index
Gerhard Ehninger has an i10-index of 599 in OpenAlex.
What is the ORCID of Gerhard Ehninger?
ScholarIQorcid
The ORCID for Gerhard Ehninger is on the source record.
What is the OpenAlex record for Gerhard Ehninger?
ScholarIQopenalex
The OpenAlex for Gerhard Ehninger is on the source record.
What are the most-cited papers on Gerhard Ehninger?
ScholarIQmost cited works
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
Christian Thiede, Christine Steudel, Brigitte Mohr, Markus Schaich, Ulrike Schäkel, Uwe Platzbecker, Martin Wermke, Martin Bornhäuser, Markus Ritter, Andreas Neubauer, Gerhard Ehninger, Thomas Illmer
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
Uwe Platzbecker, Martin Wermke, J. Radke, Uta Oelschlaegel, Franzi Seltmann, Alexander Kiani, I-M Klut, Holger Knoth, Christoph Röllig, Johannes Schetelig, Brigitte Mohr, Xina Graehlert, Gerhard Ehninger, Martin Bornhäuser, Christian Thiede
Rapamycin extends murine lifespan but has limited effects on aging
Frauke Neff, Diana Flores-Dominguez, Devon Ryan, Marion Horsch, Susanne Schröder, Thure Adler, Luciana Caminha Afonso, Juan Antonio Aguilar‐Pimentel, Lore Becker, Lillian Garrett, Wolfgang Hans, Moritz M. Hettich, Richard Holtmeier, Sabine M. Hölter, Kristin Moreth, Cornelia Prehn, Oliver Puk, Ildikó Rácz, Birgit Rathkolb, Jan Rozman, Beatrix Naton, Rainer Ordemann, Jerzy Adamski, Johannes Beckers, Raffi Bekeredjian, Dirk H. Busch, Gerhard Ehninger, Jochen Graw, Heinz Höfler, Martin Klingenspor, Thomas Klopstock, Markus Ollert, Jörg Stypmann, Eckhard Wolf, Wolfgang Wurst, Andreas Zimmer, Helmut Fuchs, Valérie Gailus‐Durner, Martin Hrabě de Angelis, Dan Ehninger
Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
Armin Ehninger, Michael Krämer, Christoph Röllig, Christian Thiede, Martin Bornhäuser, Malte von Bonin, Martin Wermke, Anja Feldmann, Michael Bachmann, Gerhard Ehninger, Uta Oelschlägel, on behalf of the Study Alliance Leukemia
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial
Christoph Röllig, Christian Thiede, Martin Gramatzki, Walter E. Aulitzky, H. Bodenstein, Martin Bornhäuser, Uwe Platzbecker, Reingard Stuhlmann, Ulrich S. Schuler, Silke Soucek, Michael Krämer, Brigitte Mohr, Uta Oelschlaegel, Friedrich Stölzel, Malte von Bonin, Martin Wermke, Hannes Wandt, Gerhard Ehninger, Markus Schaich, for the Study Alliance Leukemia